TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
STRO

Sutro Biopharma

Healthcare · Biotechnology

15.30$ -0.9% vs. previous close Closing price · As of: Sep 18, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Sutro Biopharma (STRO) with date, type and a link to the original document.

Filings STRO
Date Type Filing Original
08/12/2026 Current report (8-K) SUTRO BIOPHARMA, INC. (STRO): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits View report ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?